Advisory Services Network’s Rigel Pharmaceuticals RIGL Stock Holding History

Advisory Services Network’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-501	Closed	-$13.5K	–	4106
2026 Q1	$13.5K	Sell	501 -43,165	-99%	-$1.45M	﹤0.01%	3400
2025 Q4	$1.87M	Buy	43,666 +11,945	+38%	+$450K	0.03%	624
2025 Q3	$899K	Buy	+31,721	New	+$949K	0.01%	915
2024 Q1	–	Sell	-270	Closed	-$3.92K	–	3196
2023 Q4	$3.92K	Buy	+270	New	+$2.76K	﹤0.01%	3194
2023 Q2	–	Sell	-200	Closed	-$2.64K	–	3180
2023 Q1	$2.64K	Hold	200	–	–	﹤0.01%	3362
2022 Q4	$3K	Buy	+200	New	+$1.83K	﹤0.01%	3290
2021 Q3	–	Sell	-13	Closed	-$1K	–	2839
2021 Q2	$1K	Buy	+13	New	+$491	﹤0.01%	3497
2021 Q1	–	Sell	-13	Closed	–	–	2608
2020 Q4	$0	Sell	13 -20	-61%	-$579	﹤0.01%	3636
2020 Q3	$1K	Buy	+33	New	+$810	﹤0.01%	3388
2020 Q2	–	Sell	-21	Closed	–	–	2380
2020 Q1	$0	Hold	21	–	–	﹤0.01%	3246
2019 Q4	$0	Buy	+21	New	+$432	﹤0.01%	3225

Other funds holding RIGL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisory Services Network's RIGL Position: Q2 2026 in Review

Advisory Services Network sold out of Rigel Pharmaceuticals (RIGL) in Q2 2026, closing a stake of 501 shares — an estimated $13.5K sold.

Advisory Services Network first reported a position in RIGL in Q4 2019 and held it in 11 quarters. The position peaked at $1.87M in Q4 2025. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

Advisory Services Network reported no remaining Rigel Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 501 Rigel Pharmaceuticals shares in Q2 2026, an estimated $13.5K.
Advisory Services Network first reported a position in Rigel Pharmaceuticals in Q4 2019 and held it in 11 quarters.
Advisory Services Network's Rigel Pharmaceuticals position peaked at $1.87M in Q4 2025.
156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.